Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Du

Showing results (651-660 of 818) with videos related to

Pageof 82
Sort By:
Osteoarthritis and Cartilage|September 12, 2018
A novel FGFR1-binding peptide attenuates the degeneration of articular cartilage in adult miceQ Tan, B Chen, Q Wang, et al.
Plos Pathogens|May 30, 2015
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding SiteEma T Crooks, Tommy Tong, Bimal Chakrabarti, et al.
Zhonghua Yi Xue Za Zhi|November 14, 2023
[Effect of recombinant human thrombin for hemostasis in liver resection: a randomized controlled phase Ⅲ clinical trial]S Yan, C Y Tu, C Y Du, et al.
Nature Materials|June 13, 2017
Intrinsically patterned two-dimensional materials for selective adsorption of molecules and nanoclustersX Lin, J C Lu, Y Shao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
<sup>177</sup>Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trialJ Xu, J Chen, S Song, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022
[Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms]M Bao, D Y Shi, H X Shi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 25, 2023
[Clinical and genetic characteristics of young patients with myeloproliferative neoplasms]M Y Zhang, M Bao, D Y Shi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 8, 2024
[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study]X S Zhang, B C Liu, X Du, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2023
[To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia]X S Zhang, B C Liu, X Du, et al.
Physical Review Letters|October 15, 2008
Anomalous line shape of the cross section for e{+}e{-}--> hadrons in the center-of-mass energy region between 3.650 and 3.872 GeVM Ablikim, J Z Bai, Y Ban, et al.
Pageof 82

Showing results (651-660 of 818) with videos related to

Sort By:
Pageof 82
Osteoarthritis and Cartilage|September 12, 2018
A novel FGFR1-binding peptide attenuates the degeneration of articular cartilage in adult miceQ Tan, B Chen, Q Wang, et al.
Plos Pathogens|May 30, 2015
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding SiteEma T Crooks, Tommy Tong, Bimal Chakrabarti, et al.
Zhonghua Yi Xue Za Zhi|November 14, 2023
[Effect of recombinant human thrombin for hemostasis in liver resection: a randomized controlled phase Ⅲ clinical trial]S Yan, C Y Tu, C Y Du, et al.
Nature Materials|June 13, 2017
Intrinsically patterned two-dimensional materials for selective adsorption of molecules and nanoclustersX Lin, J C Lu, Y Shao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
<sup>177</sup>Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trialJ Xu, J Chen, S Song, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022
[Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms]M Bao, D Y Shi, H X Shi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 25, 2023
[Clinical and genetic characteristics of young patients with myeloproliferative neoplasms]M Y Zhang, M Bao, D Y Shi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 8, 2024
[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study]X S Zhang, B C Liu, X Du, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2023
[To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia]X S Zhang, B C Liu, X Du, et al.
Physical Review Letters|October 15, 2008
Anomalous line shape of the cross section for e{+}e{-}--> hadrons in the center-of-mass energy region between 3.650 and 3.872 GeVM Ablikim, J Z Bai, Y Ban, et al.
Pageof 82